Giordano TJ - Search Results

1

CDX2 polymorphisms, RNA expression, and risk of colorectal cancer.

Rozek LS, Lipkin SM, Fearon ER, Hanash S, Giordano TJ, Greenson JK, Kuick R, Misek DE, Taylor JM, Douglas JA, Rennert G, Gruber SB. Rozek LS, et al. Among authors: giordano tj. Cancer Res. 2005 Jul 1;65(13):5488-92. doi: 10.1158/0008-5472.CAN-04-3645. Cancer Res. 2005. PMID: 15994917

2

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.

Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG, Hanash SM. Brichory FM, et al. Among authors: giordano tj. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9824-9. doi: 10.1073/pnas.171320598. Proc Natl Acad Sci U S A. 2001. PMID: 11504947 Free PMC article.

3

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.

Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N, Misek DE, Greenson JK, Kardia SL, Beer DG, Rennert G, Cho KR, Gruber SB, Fearon ER, Hanash S. Giordano TJ, et al. Am J Pathol. 2001 Oct;159(4):1231-8. doi: 10.1016/S0002-9440(10)62509-6. Am J Pathol. 2001. PMID: 11583950 Free PMC article.

4

Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.

Brichory F, Beer D, Le Naour F, Giordano T, Hanash S. Brichory F, et al. Cancer Res. 2001 Nov 1;61(21):7908-12. Cancer Res. 2001. PMID: 11691811

5

Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.

Le Naour F, Misek DE, Krause MC, Deneux L, Giordano TJ, Scholl S, Hanash SM. Le Naour F, et al. Among authors: giordano tj. Clin Cancer Res. 2001 Nov;7(11):3328-35. Clin Cancer Res. 2001. PMID: 11705844

6

Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.

Thomas DG, Giordano TJ, Sanders D, Biermann JS, Baker L. Thomas DG, et al. Among authors: giordano tj. Clin Cancer Res. 2002 Mar;8(3):788-93. Clin Cancer Res. 2002. PMID: 11895910

7

Discordant protein and mRNA expression in lung adenocarcinomas.

Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Chen G, et al. Among authors: giordano tj. Mol Cell Proteomics. 2002 Apr;1(4):304-13. doi: 10.1074/mcp.m200008-mcp200. Mol Cell Proteomics. 2002. PMID: 12096112 Free article.

8

Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.

Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Chen G, et al. Among authors: giordano tj. Clin Cancer Res. 2002 Jul;8(7):2298-305. Clin Cancer Res. 2002. PMID: 12114434

9

Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S. Beer DG, et al. Among authors: giordano tj. Nat Med. 2002 Aug;8(8):816-24. doi: 10.1038/nm733. Epub 2002 Jul 15. Nat Med. 2002. PMID: 12118244

10

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR. Schwartz DR, et al. Among authors: giordano tj. Cancer Res. 2002 Aug 15;62(16):4722-9. Cancer Res. 2002. PMID: 12183431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters